Swiss-MadeN° 01 — Metabolic research
Tirzepatide60MG
Dual GIP / GLP-1 receptor agonist
Tirzepatide is a 39-amino-acid synthetic peptide engineered to activate both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual mechanism has made it one of the most widely studied molecules in modern metabolic research.
Neochemi Tirzepatide is supplied as a lyophilized peptide, HPLC-verified to ≥99% purity and released only after batch-level analytical review.
| Purity | ≥99% (HPLC verified) |
|---|---|
| Content | 60 mg per vial |
| Presentation | Lyophilized peptide · 1 vial |
| CAS number | 2023788-19-2 |
| Molecular formula | C₂₂₅H₃₄₈N₄₈O₆₈ |
| Molecular weight | 4813.5 g/mol |
| Sequence | 39 amino acids |
| Storage | −20 °C, protected from light |
| Origin | Switzerland · Swiss-Made |
Mechanism of interest
Two pathways.
One molecule.
Tirzepatide is studied for its activity on two incretin receptors at once — GIP and GLP-1 — a dual profile that sets it apart from single-receptor analogues.
Conceptual visual representation. Not a depiction of molecular structure.
